|4Dec 18, 4:16 PM ET

Kelsey Stephen Michael 4

4 · Revolution Medicines, Inc. · Filed Dec 18, 2025

Insider Transaction Report

Form 4
Period: 2025-12-16
Transactions
  • Sale

    Common Stock

    2025-12-16$76.82/sh5,447$418,423278,600 total
Footnotes (2)
  • [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
  • [F2]Includes 73,576 restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary